Breast cancer is the most common cancer among women in the United States ([@b62-ehp0113-000993]) and the leading cause of cancer death among women 35--54 years of age ([@b58-ehp0113-000993]). Fueled by concern over the concurrent increase in breast cancer incidence with the widespread emergence of large-scale agricultural pesticide use \[[@b89-ehp0113-000993]\], considerable research has been conducted on the relationship between pesticide exposures and breast cancer. Substantial evidence from laboratory and animal studies indicates that many pesticides are carcinogenic ([@b11-ehp0113-000993]; [@b18-ehp0113-000993]; [@b21-ehp0113-000993]; [@b77-ehp0113-000993]; [@b88-ehp0113-000993]) and/or xenoestrogens ([@b41-ehp0113-000993]; [@b59-ehp0113-000993]; [@b25-ehp0113-000993]). The risks posed to human populations from low-level environmental contamination, however, are largely unknown. California, which boasts a \$25 billion agricultural industry, is the largest agricultural state in the United States \[[@b87-ehp0113-000993]\]; it is also home to some of the world's highest breast cancer rates ([@b63-ehp0113-000993]).

This study was initiated in response to growing concern about potential exposures to current pesticide applications among agricultural community residents ([@b79-ehp0113-000993]). Using 10 years of statewide cancer registry data, linked to California's mandatory pesticide use reporting data, we evaluated whether breast cancer rates are higher among women living in areas with recent intense agricultural pesticide use. With more than 176,000 breast cancer cases and nearly 71 million person-years of observation among an ethnically diverse population in a large agricultural state, this study offers sufficient detail and power to provide a broad initial overview of breast cancer incidence patterns and potential environmental exposures to agricultural pesticide use.

Materials and Methods
=====================

Cancer Incidence Data
---------------------

We identified all invasive breast cancer cases diagnosed in women ≥ 20 years of age from the California Cancer Registry (CCR), for 1988 through 1997 (*n* = 181,080) (CCR 2005). Modeled after the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program, the CCR maintains the highest standards for data quality and completeness; their data are estimated to be 99% complete and include case sharing from neighboring states ([@b47-ehp0113-000993]). Case characteristics, including race, age, sex, and residence at time of diagnosis, are collected by the CCR from patients' medical records. Use of human subjects' data in this study was reviewed and approved by the California Health and Human Services Agency, Committee for the Protection of Human Subjects.

Geocoding
---------

We assigned census block group designations to cases based on the geocoded location of residence at the time of diagnosis. We completed this task using a geographic information system (GIS) to automatically match addresses with a road network and determine the corresponding census block group. When possible, we manually located all addresses that could not be automatically matched using the GIS. Because most addresses not automatically geocoded were post office boxes, we augmented our manual review with a mailed survey to U.S. postmasters, requesting street addresses for CCR records that contained only a post office box address ([@b40-ehp0113-000993]). Overall, we successfully geocoded 97.4% of cases (176,302 of 181,080) to a 1990 census block group \[[@b30-ehp0113-000993]; [@b84-ehp0113-000993]\].

Pesticide Data
--------------

California's Department of Pesticide Regulation maintains a pesticide use reporting (PUR) database that includes detailed information on all agricultural pesticide applications in the state, including the active ingredient, application method, quantity applied, acres treated, crop treated, and location (in square mile sections). Pesticides included in the PUR database include all insecticides, herbicides, fungicides, and fumigants applied for agricultural purposes. Full use reporting began in 1990; therefore, we used PUR data reported from 1990 through 1997 to calculate the annual average pesticide use in each square mile section of California ([@b13-ehp0113-000993]). For our analysis, we combined pesticides into six toxicologic groups and also selected five individual pesticides for examination based on their carcinogenic and exposure potential.

### Toxicologic groups of pesticides.

More than 850 different pesticides were reported to the PUR system during our study period, making analysis of each individual pesticide impractical. Therefore, we combined pesticides into six toxicologic groups for our analysis: probable or likely carcinogens, possible or suggestive carcinogens, mammary carcinogens, xenoestrogens, cholinesterase inhibitors, and organochlorines. Some pesticides belong to more than one group. [Table 1](#t1-ehp0113-000993){ref-type="table"} lists the individual pesticides that comprise each of these groups. Our purpose for categorizing the pesticides was to study exposures to chemicals with similar toxicity end points relevant to breast cancer because, in reality, exposures occur to mixtures of chemicals and total risk may be underestimated by studying individual exposures.

California banned or severely restricted all pesticides classified as known human carcinogens before the time of this study. The carcinogenic evidence for the pesticides we assessed is based almost exclusively on laboratory animal studies ([@b18-ehp0113-000993]). Given these data, we combined 16 pesticides classified as probable or likely human carcinogens ([@b88-ehp0113-000993]). Similarly, we combined 35 pesticides classified as possible or suggestive human carcinogens ([@b88-ehp0113-000993]). We identified four pesticides as potential human mammary carcinogens, based on excess mammary tumors in laboratory animal studies ([@b25-ehp0113-000993]; [@b88-ehp0113-000993]). For the purpose of this study, we defined xenoestrogens as any pesticides that directly or indirectly increase estrogenic effects and may ultimately lead to mammary cell proliferation. We identified 34 pesticides used in California as potential xenoestrogens ([@b18-ehp0113-000993]; [@b25-ehp0113-000993]; [@b41-ehp0113-000993]). We chose cholinesterase inhibitors as a category because they represent two specific pesticide groups---organophosphates and carbamates---both of which have the potential to increase estrogenic activity by acting on the hypothalamic-pituitary axis ([@b12-ehp0113-000993]; [@b25-ehp0113-000993]). We chose organochlorines as a category because of their persistence in the body and the environment and because of extensive evidence for estrogenicity ([@b78-ehp0113-000993]). We identified only three organochlorine pesticides as being used in California between 1990 and 1997. These pesticide groupings are the same as those used in an earlier study of breast cancer incidence in a large statewide cohort study ([@b67-ehp0113-000993]).

### Selection of individual pesticides.

We selected five pesticides for individual analysis: simazine, diuron, oryzalin, propargite, and methyl bromide. The first three have established toxicologic data from laboratory animal studies implicating their role in mammary tumorigenesis and are also considered xenoestrogens ([@b18-ehp0113-000993]; [@b25-ehp0113-000993]; [@b41-ehp0113-000993]; [@b59-ehp0113-000993]; [@b88-ehp0113-000993]). We selected the final two pesticides, propargite and methyl bromide, because they were the two top-ranking chemicals identified by our cancer hazard ranking system for pesticides, indicating they were the most widely used with the greatest exposure potential and likelihood of being carcinogenic in California during our study period.

Detailed methods for our cancer hazard ranking system for pesticides are presented elsewhere ([@b32-ehp0113-000993]). Briefly, we assigned each pesticide a hazard score based on two carcinogenicity measures (cancer class and potency) and two exposure potential measures (field volatilization flux and half-life). We then multiplied each pesticide's hazard score with the average annual pounds of that pesticide applied statewide from 1990 through 1997 to derive the cancer hazard-adjusted use. We identified 59 pesticides with ≥ 100,000 lb/year used in California, for which all the necessary toxicity and environmental data were available. Methyl bromide and propargite ranked highest among these 59 pesticides for hazard-adjusted use during the time period of interest (1990--1997).

### Pesticide exposure assessment.

We used PUR data reported from 1990 through 1997 to calculate the annual average pesticide use in each square mile section of California ([@b13-ehp0113-000993]). Using a GIS (ArcView, version 3.0; Environmental Systems Research Institute Inc., Redlands, CA), we identified all square-mile sections located within each census block group. If a section fell into more than one block group, we allocated the pesticide use based on the percent area of the section in each block group. In 1990, California block groups had a median land area of 0.2 mi^2^, with a range between 0.0001 and 3,610 mi^2^ ([@b84-ehp0113-000993]). We estimated the average annual agricultural pesticide use during the study period, for each block group, by summing the average pounds applied in all relevant sections and then dividing by the block group area to obtain pesticide use density in pounds per square mile.

### Population data.

We based our rate calculations on population estimates derived from census data compiled at the U.S. Census block group level. Inconsistencies in data collection between the 1990 and 2000 censuses required specialized development of denominator estimates. For this purpose, we obtained two customized data sets through special permission from the Census Activities and Tabulation Staff, Population Division, of the U.S. Census Bureau (U.S. Census Bureau, unpublished data). The two data sets, which contained mutually exclusive categories for race and Hispanic origin, consisted of block group counts of all women in California, ≥ 20 years of age, by race and Hispanic origin at 5-year age increments, one from the 1990 Census and the other from the 2000 Census. After adjusting for differences in geographic boundaries and race designations between the two censuses, we used linear interpolation to estimate annual age- and race-specific population counts for all block groups in the state. The denominator used in the analysis is the summed annual age- and race-specific block group population counts for 1988 through 1997. A description of this process is presented in more detail elsewhere ([@b66-ehp0113-000993]).

### Covariate information. Race/ethnicity.

We derived race/ethnicity information for the California population from the 1990 and 2000 Census data as described above. We obtained the race/ethnicity of cases from the CCR data. The categories used for analysis were non-Hispanic white, black, Hispanic, Asian/Pacific Islander, and other. The "other" category included American Indian, other, and non-specified groups.

### Socioeconomic status and urbanization.

We characterized the socioeconomic status (SES) and degree of urbanization of every census block group in California using additional 1990 census data ([@b83-ehp0113-000993]). We created a summary SES metric incorporating occupation, education, and income. To do this, we first ranked all California block groups separately by education level (percentage of adults ≥ 25 years of age completing a college degree or higher), income (median family income), and occupation (percentage of adults employed in managerial/professional occupations) according to quartiles, based on the statewide adult population. This resulted in a score of 1--4 for each of these SES attributes. We then created a summary SES metric by summing the scores across each of the four SES attributes and categorizing them into four groups (high to low), based on the quartiles of this score. Because this SES metric was based on all adults (not just women) and because of differential population growth across California block groups since 1990, the person-years in our study do not distribute evenly across SES quartiles.

To define the degree of urbanization, we used a combination of census-based information. The U.S. Census Bureau defines an urbanized area as a centralized area, with a population of ≥ 50,000 people and a population density of at least 1,000 people per square mile ([@b85-ehp0113-000993]). Because, by this definition, 85% of California residents live in an urban area, we used additional information to refine the urbanization measure. Our categorization, which we based primarily on population and ultimately refined with population density, included four values: "metropolitan urban" represented block groups with the highest quartile of population density within U.S. Census--defined urbanized areas (i.e., population \> 1,000,000); "metropolitan suburban" included the rest of the population within census-defined urbanized areas; "city" included census-defined places with \> 50,000 people, outside of an urbanized area; and "small town/rural" included census-defined places with \< 50,000 people outside of an urbanized area.

### Age group.

We obtained age at diagnosis from the CCR and categorized women into 5-year age groups for covariate adjustment in regression models. There is substantial evidence that risk factors for breast cancer are somewhat different for pre- versus postmenopausal diagnoses ([@b19-ehp0113-000993]). Unfortunately, information on menopausal status was not available for either the cases or the statewide population. To evaluate whether risks associated with pesticide use density differed for pre- and post-menopausal breast cancer incidence, we used age at diagnosis as a proxy for menopausal status and created three groups: 20--44 years of age to approximate a premenopausal group, 45--54 years of age to represent an approximate perimenopausal group, and ≥ 55 years of age as a proxy for postmenopausal women ([@b57-ehp0113-000993]). We did not include these broad age categories in the regression models as covariates but rather used them only to stratify the data.

Analysis
--------

Because our toxicologic groupings and individual pesticides were highly correlated, and not necessarily mutually exclusive, we looked at the six pesticide groupings and five individual pesticides in separate statistical models. For each group or individual pesticide, we considered block groups with pesticide use density of \< 1 lb/mi^2^ to have negligible exposure potential; these served as our reference category or "unexposed" group. We based our other three pesticide use categories on the distributions of pesticide use densities among subjects with ≥ 1 lb/mi^2^ of use density: 1st--49th percentiles, 50th--74th percentiles, and ≥ 75th percentile.

We computed rate ratios and 95% confidence intervals (CIs) using Poisson regression models run with the GENMOD procedure in SAS (version 8.0e; SAS Institute Inc., Cary, NC). We calculated rate ratios for each level of pesticide use density for the six pesticide groupings and five individual pesticides, initially adjusting for age and race. Subsequent models also adjusted for neighborhood SES and urbanization. Our previous work with these data, and that of others, indicated that the breast cancer risk associated with SES varies by race/ethnicity ([@b66-ehp0113-000993]; [@b100-ehp0113-000993]). Therefore, our final regression models also contained a multiplicative interaction term for race/ethnicity and SES. We then repeated these analyses, stratifying by age group and degree of urbanization (urban, suburban, city, small town/rural) to evaluate potentially different risk relationships among these subgroups. We performed all analyses with SAS.

Initial evaluations of the deviance and Pearson chi-square generalized statistics from our Poisson models suggested overdispersion in our data ([@b72-ehp0113-000993]). Such overdispersion can result from sparse data, variations in an assumed constant rate of event occurrence, and/or unexplained heterogeneity and can lead to biased estimates of the standard errors in Poisson regression ([@b6-ehp0113-000993]). Employing a rescaling approach to address issues of overdispersion in our data, we multiplied the covariance matrix by a dispersion parameter, which was estimated based on the Pearson chi-square statistic ([@b52-ehp0113-000993]; [@b72-ehp0113-000993]). This adjustment does not change the risk estimates, but inflates the standard errors to adjust for overdispersion. We also evaluated an alternative approach for modeling the data using negative binomial regression, a generalization of the Poisson model that incorporates heterogeneity ([@b6-ehp0113-000993]). Because the results from the two methods were essentially the same, we have reported the results from the Poisson models run with the rescaled standard errors. This seems to be the more familiar statistical approach and is the one recently employed in a Marin, California, breast cancer study ([@b7-ehp0113-000993]).

Results
=======

This analysis included 176,302 invasive breast cancer cases among the California adult female population, with 70,968,598 person-years of observation. [Table 2](#t2-ehp0113-000993){ref-type="table"} shows the distribution of selected characteristics for the breast cancer cases and the California adult female population for the study period (1988--1997). As expected, cases were more likely than the adult female statewide population to be older and non-Hispanic white. Cases were also slightly more likely than the general population to live in suburban and higher SES neighborhoods. Previously published age-adjusted rate ratios for these demographic factors among this study population were consistent with other published data on these factors ([@b66-ehp0113-000993]).

[Table 3](#t3-ehp0113-000993){ref-type="table"} shows the distribution of annual agricultural pesticide use density among the California census block groups included in these analyses. The number of block groups in the study with annual pesticide use density of ≥ 1 lb/mi^2^ for a given pesticide group ranged from 1,633 (8% of block groups) for organochlorines to 7,871 (37% of block groups) for xenoestrogens. The highest use density was for xenoestrogens, with a median application rate of 42 lb/mi^2^. For individual pesticides, the number of block groups in the study with annual pesticide use density ≥ 1 lb/mi^2^ for a given pesticide ranged from 1,823 (9% of block groups) for diuron to 4,100 (19% of block groups) for methyl bromide. The highest use density was for methyl bromide, with a median annual application rate of 125 lb/mi^2^.

[Table 4](#t4-ehp0113-000993){ref-type="table"} presents the rate ratios obtained from the Poisson regression models predicting breast cancer risk associated with residential proximity to agricultural pesticide use. In the models adjusting for only age and race, point estimates for all use densities above the referent (\< 1 lb/mi^2^) were \< 1 for all groupings and individual pesticides considered, and in many cases, the 95% CIs included 1. Although the age- and race-adjusted rate ratios for simazine, oryzalin, propargite, and methyl bromide were all significantly \< 1, additional adjustment for neighborhood SES and urbanization resulted in point estimates that did not significantly differ from 1. Likewise, in the fully adjusted models none of the rate ratios significantly differed from unity for any of the groupings or individual pesticides considered at any exposure level.

Discussion
==========

This study represents a broad assessment of the relationship between agricultural pesticide use patterns and breast cancer incidence in women in a large and diverse agricultural state. The results provide no evidence that women living in areas of recent, high agricultural pesticide use experience higher breast cancer incidence rates. This lack of association was evident for all three age groups examined and did not differ between women living in urban and rural areas.

Much of the epidemiologic research on this topic has focused on examining the relationship between breast cancer and body burden levels of organochlorine pesticides (as measured in serum or adipose). Generally, results from these types of studies have been null ([@b2-ehp0113-000993]; [@b15-ehp0113-000993]; [@b48-ehp0113-000993]; [@b70-ehp0113-000993]; [@b78-ehp0113-000993]; [@b98-ehp0113-000993]), although a few well-designed studies have reported positive associations ([@b3-ehp0113-000993]; [@b36-ehp0113-000993], [@b37-ehp0113-000993]; [@b68-ehp0113-000993]). One of the notable limitations of these studies, however, has been that they were able to evaluate only the relatively small number of compounds that are persistent and detectable by current analytic methods, with most focused on dichlorodiphenyltrichlorethane (DDT) or its metabolite dichlorodiphenyldichloroethylene (DDE) ([@b4-ehp0113-000993]; [@b16-ehp0113-000993]; [@b17-ehp0113-000993]; [@b20-ehp0113-000993]; [@b26-ehp0113-000993]; [@b38-ehp0113-000993]; [@b45-ehp0113-000993]; [@b48-ehp0113-000993]; [@b49-ehp0113-000993]; [@b53-ehp0113-000993]; [@b54-ehp0113-000993]; [@b60-ehp0113-000993]; [@b68-ehp0113-000993]; [@b73-ehp0113-000993]; [@b82-ehp0113-000993]; [@b90-ehp0113-000993]; [@b93-ehp0113-000993]; [@b97-ehp0113-000993], [@b99-ehp0113-000993]; [@b101-ehp0113-000993]). Furthermore, many of these studies have measured these compounds in blood or adipose collected at the time of diagnosis, which may not reflect exposures occurring during more etiologically relevant time periods, such as prenatal or adolescent growth ([@b64-ehp0113-000993]). Although the exposure estimates used in our analysis can account for a broader spectrum of potentially suspect agents, our lack of residential history information poses the same temporal limitation.

Occupational studies on this issue are quite mixed, with some suggesting a positive association between breast cancer and work-related pesticide exposures ([@b5-ehp0113-000993]; [@b24-ehp0113-000993]; [@b29-ehp0113-000993]; [@b44-ehp0113-000993]) and others reporting no association ([@b22-ehp0113-000993]; [@b27-ehp0113-000993], [@b28-ehp0113-000993]; [@b50-ehp0113-000993]; [@b80-ehp0113-000993]; [@b92-ehp0113-000993]; [@b94-ehp0113-000993]; [@b102-ehp0113-000993]) or even a protective effect ([@b46-ehp0113-000993]; [@b76-ehp0113-000993]). These studies, however, have been limited by small numbers of women, an inability to control for other breast cancer risk factors, reliance on sometimes crude proxy measures of exposure and potential "healthy worker" biases in cohort studies using external population comparisons.

Similar to our study, a number of ecologic (aggregative) analyses have been conducted to examine the potential relationship between environmental exposures to agricultural pesticide use and breast cancer ([@b1-ehp0113-000993]; [@b9-ehp0113-000993]; [@b35-ehp0113-000993]; [@b42-ehp0113-000993]; [@b43-ehp0113-000993]; [@b61-ehp0113-000993]; [@b67-ehp0113-000993]; [@b71-ehp0113-000993]; [@b74-ehp0113-000993]; [@b75-ehp0113-000993]; [@b95-ehp0113-000993]). Again, the results from these studies are mixed, with some suggesting a positive association ([@b9-ehp0113-000993]; [@b42-ehp0113-000993]; [@b43-ehp0113-000993]; [@b61-ehp0113-000993]; [@b95-ehp0113-000993]) and others not ([@b1-ehp0113-000993]; [@b35-ehp0113-000993]; [@b67-ehp0113-000993]; [@b74-ehp0113-000993]; [@b75-ehp0113-000993]).

A number of limitations common to ecologic (aggregative) studies are worth noting. Because data are summarized for groups of individuals, inferences can be made only about populations rather than individuals ([@b31-ehp0113-000993]; [@b55-ehp0113-000993], [@b56-ehp0113-000993]). The primary limitation of such study designs is that the heterogeneity of exposure and covariate levels within groups is not fully captured with ecologic data. This can lead to ecologic effect estimates that do no reflect the biologic effect at the individual level---commonly referred to as "ecologic bias" ([@b31-ehp0113-000993]; [@b55-ehp0113-000993], [@b56-ehp0113-000993]). Although our study, by virtue of its design, cannot completely escape this limitation, the small unit of analysis used in our study helps reduce the within-group heterogeneity. Ecologic studies such as this one, however, have a number of advantages as well ([@b55-ehp0113-000993], [@b56-ehp0113-000993]; [@b91-ehp0113-000993]). By using monitoring data, ecologic studies can estimate potential ambient exposures that do not lend themselves to subject recall. Furthermore, our study population was large and geographically dispersed. This provided variability in potential exposures not often available from other epidemiologic study designs. The variability in exposure and large sample size combine to offer statistical power sufficient to detect small risks that, if large numbers of people are exposed, may be very important from a public health standpoint. Thus, although our study certainly has some limitations, it also offers some advantages over other traditional epidemiologic study designs.

Our study has a number of advantages over many of the ecologic studies conducted to date. Because ours was a study of incidence rather than mortality, we could more directly evaluate potential risk relationships without potential confounding by factors related to prognosis. We were able to evaluate classes of chemicals and individual chemicals of interest specific to breast cancer, whereas many of the previous studies relied on measures that are more global (e.g., total pounds of all pesticides applied) or used acreage of specific crop types as proxy measures for classes of pesticide exposures. Additionally, we were able to evaluate pesticide applications on a small scale (census block group); most other ecologic studies have estimated exposures over larger areas, such as counties---a method that is likely to result in greater exposure misclassification ([@b69-ehp0113-000993]).

The ability to control for area differences in SES and urbanization is especially important, given that regions of intense agricultural pesticide use are often rural and of low SES, whereas breast cancer rates tend to be higher in upper SES ([@b33-ehp0113-000993]; [@b34-ehp0113-000993]; [@b66-ehp0113-000993]; [@b81-ehp0113-000993]; [@b100-ehp0113-000993]) and more urban areas ([@b23-ehp0113-000993]; [@b51-ehp0113-000993]; [@b66-ehp0113-000993]). Because lifestyle factors related to breast cancer risk, such as physical activity, smoking, alcohol consumption, and childbearing patterns, are likely to differ between rural and urban areas in a way that would favor lower breast cancer rates in rural areas, where pesticide use is typically high ([@b65-ehp0113-000993]), it is essential to account for urbanization in analyses of breast cancer and agricultural pesticide use. Because of our study's large size, we were able to evaluate pesticide use and breast cancer separately among rural and urban women.

The results from our study agree with an earlier analysis of agricultural pesticide use we performed among members of the California Teachers Study (CTS) cohort ([@b67-ehp0113-000993]). The CTS, a cohort of nearly 134,000 female California professional school employees geographically dispersed throughout the state, was specifically designed to study breast cancer ([@b8-ehp0113-000993]). Thus, in the CTS analysis we were able to adjust for known breast cancer risk factors, something we were not able to do in this statewide study. Furthermore, in the CTS analysis, we estimated potential pesticide exposures at a very small scale (within a half-mile radius for each individual). Evaluating the same toxicologic categorizations and individual pesticides as in the statewide study, we saw no evidence of an association with recent pesticide use and breast cancer incidence within the CTS cohort ([@b67-ehp0113-000993]).

Both the statewide study presented here and our earlier analysis in the CTS cohort, are limited in that they are designed to determine whether breast cancer rates are higher in areas with recent high agricultural pesticide use. The results from both studies suggest not. The lack of an association in these studies, however, reflects only on reasonably concurrent exposure/outcome relationships and does not account for sources of broader exposures to pesticides or time windows of potential vulnerability. Furthermore, evaluating the long-term health effects of exposure to a single pesticide is difficult at the population level because of relatively low exposure levels, uncertainty regarding those exposure levels, and the use of many pesticides simultaneously in some census block groups.

Unfortunately, preexisting historical data on agricultural pesticide use, in conjunction with data on residential histories for those with or at risk of breast cancer, are neither readily available nor easy to collect. In California, agricultural pesticide use has been fairly consistent statewide, with basically the same counties, crops, and pesticides ranking highest in use year after year since full reporting was implemented in 1990 ([@b96-ehp0113-000993]). Reporting was not required for all agricultural pesticide use in the 1980s, but the restricted pesticide use reporting data indicate a similar consistency of rankings throughout the decade ([@b14-ehp0113-000993]). GIS mapping of pesticide use patterns in the 1980s compared with the 1990s, however, showed there has been some change at the neighborhood level because former cropland and surrounding buffers have been turned into residential areas.

Although the U.S. Census Bureau provides data on residential stability for households but not for individuals, these data suggest a fairly mobile population in California. Census 2000 data indicate that only 31% of occupied California households in 2000 were occupied by the same householder for more than 10 years ([@b86-ehp0113-000993]). A previous analysis of participants in a breast cancer study among a cohort of California teachers, however, reported that residential stability may be greater among older women and women living in high SES neighborhoods ([@b39-ehp0113-000993]).

The inability to incorporate information on residential mobility and historical use patterns in this study introduces an important source of potential exposure misclassification. Although this limits our ability to evaluate etiologic relationships, our study was designed in response to public concern about exposures to current agricultural pesticide applications ([@b79-ehp0113-000993]). Our results indicate that women living in areas of intense, recent agricultural pesticide use do not have higher breast cancer rates. Determining whether girls or young women living in these areas will be at greater risk of breast cancer in future years is a topic of continuing interest but beyond the scope of our study.

Recently, results were published from two case--control studies that tried to address the issue of historical agricultural pesticide exposures and breast cancer ([@b9-ehp0113-000993]; [@b61-ehp0113-000993]). A small case--control study (*n* = 105 cases) nested within a cohort of long-term residentially stable women living on Long Island, New York, used several different data sources to estimate historical exposures to agricultural pesticides ([@b61-ehp0113-000993]). The authors reported an increased breast cancer risk associated with residence within a mile of a hazardous waste site containing pesticides \[odds ratio (OR) = 2.9; 95% CI, 1.1--7.2\] but no association with measures of residence on or near prior agricultural land (OR = 1.5; 95% CI, 0.8--2.9) or pesticides detected in drinking water (OR = 1.2; 95% CI, 0.6--2.1). These proxy exposure measures were not highly correlated, perhaps because they represent very different kinds of exposures and/or because of nonconcurrent time periods of measurement.

In a population-based case--control study of women living in Cape Cod, Massachusetts, exposure estimates were constructed dating back to 1948 from historical aerial photography and written pesticide spraying records ([@b10-ehp0113-000993], [@b9-ehp0113-000993]). Although the authors reported no overall association between pesticide use and breast cancer, modest (although not statistically significant) associations were reported for aerial applications of persistent pesticides on cranberry bogs and less persistent pesticides applied for tree pests or agriculture ([@b9-ehp0113-000993]). The Cape Cod study probably represents the most comprehensive evaluation of historical agricultural pesticide applications and breast cancer risk conducted to date, and it illustrates the complexity of constructing these kinds of risk indicators. Through GIS, the Cape Cod study was able to estimate the relative intensity of pesticide exposures associated with residences over a ≥ 40-year time span. Unlike our study, however, the Cape Cod study had limited variability in pesticide use and was not able to evaluate specific individual (or classes of) chemicals of interest.

The question of whether exposures to agricultural pesticide applications are a cause of breast cancer is obviously complex and likely to be answered only through a variety of complementary approaches. The recent advent of GIS-based technologies has enhanced our ability to characterize ambient exposures that are not easily reportable, or identifiable, on an individual basis. Studies that use GIS to integrate information across various domains, such as those being conducted on Long Island and Cape Cod, will be greatly improved by the availability of more comprehensive geographically referenced historical exposure data as they become available in the future.
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Toxicologic categorization[a](#tfn2-ehp0113-000993){ref-type="table-fn"} of agricultural pesticides used in California and reported to the PUR system, 1990--1997.

  Toxicologic group                          Individual pesticides                                                                                                                         
  ------------------------------------------ ----------------------- ------------------------------------------------------ -------------------------------------------------------------- ----------------------------------------------------------
  Probable or likely human carcinogens       Cacodylic acid          Diclofop-methyl                                        Mancozeb                                                       Propargite[b](#tfn3-ehp0113-000993){ref-type="table-fn"}
                                             Captan                  Diuron[b](#tfn3-ehp0113-000993){ref-type="table-fn"}   Maneb                                                          Propyzamide
                                             Chlorothalonil          Ethoprop                                               Metam sodium                                                   Thiophanate-methyl
                                             1,3-Dichloropropene     Iprodione                                              Orthophenylphenol                                              Ziram
  Possible or suggestive human carcinogens   Acephate                Chlorthal-dimethyl                                     Malathion                                                      Permethrin
                                             Acrolein                Cyanazine                                              Methidathion                                                   Phosmet
                                             Alachlor                Cypermethrin                                           Metolachlor                                                    Piperonyl butoxide
                                             Amitraz                 Dicofol                                                Molinate                                                       Propanil
                                             Benomyl                 Dimethoate                                             Norflurazon                                                    Simazine[b](#tfn3-ehp0113-000993){ref-type="table-fn"}
                                             Bifenthrin              Ethalfluralin                                          Oryzalin[b](#tfn3-ehp0113-000993){ref-type="table-fn"}         Triadimefon
                                             Bromacil                Hydrogen cyanamide                                     Oxyfluorfen                                                    Trifluralin
                                             Bromoxynil octanoate    Lindane                                                Parathion                                                      Vinclozolin
                                             Carbaryl                Linuron                                                Pendimethalin                                                  
  Mammary carcinogens Xenoestrogens          Atrazine                Diuron[b](#tfn3-ehp0113-000993){ref-type="table-fn"}   Oryzalin[b](#tfn3-ehp0113-000993){ref-type="table-fn"}         Simazine[b](#tfn3-ehp0113-000993){ref-type="table-fn"}
                                             Acrolein                2,4-D                                                  Methidathion                                                   Pendimethalin
                                             Alachlor                Diuron[b](#tfn3-ehp0113-000993){ref-type="table-fn"}   Methomyl                                                       Permethrin
                                             Aldicarb                Endosulfan                                             Methyl bromide[b](#tfn3-ehp0113-000993){ref-type="table-fn"}   Simazine[b](#tfn3-ehp0113-000993){ref-type="table-fn"}
                                             Atrazine                Hydrogen cyanamide                                     Metribuzin                                                     Thiophanate-methyl
                                             Benomyl                 Iprodione                                              Mevinphos                                                      Trifluralin
                                             Bromacil                Lindane                                                Molinate                                                       Vinclozolin
                                             Cacodylic acid          Malathion                                              Oryzalin[b](#tfn3-ehp0113-000993){ref-type="table-fn"}         Ziram
                                             Captan                  Mancozeb                                               Paraquat dichloride                                            
                                             Dicofol                 Maneb                                                  Parathion                                                      
  Cholinesterase inhibitors                  Acephate                Diazinon                                               Malathion                                                      Mevinphos
                                             Aldicarb                Dimethoate                                             Methamidophos                                                  Naled
                                             Azinophos methyl        Disulfoton                                             Methidathion                                                   Parathion
                                             Carbaryl                Ethephon                                               Methomyl                                                       Phorate
                                             Chlorpyrifos            Fenamiphos                                             Methyl parathion                                               Phosmet
  Organochlorines                            Dicofol                 Endrin                                                 Lindane                                                        

2,4-D, 2,4-dichlorophenoxyacetic acid.

Some pesticides fall into more than one group.

Pesticide also chosen for individual analysis.

###### 

Distribution of selected characteristics for invasive breast cancer cases (*n* = 176,302) and the California adult female population, 1988--1997 (person-years, *n* = 70,968,598).

  Characteristic                                                            Cases (%)   Person-years (%)
  ------------------------------------------------------------------------- ----------- ------------------
  Age (years)                                                                           
   20--39                                                                   6.5         16.4
   40--44                                                                   7.2         16.1
   45--49                                                                   9.7         12.9
   50--54                                                                   9.5         10.6
   55--59                                                                   9.5         8.9
   60--64                                                                   10.8        8.3
   65--69                                                                   12.7        8.0
   70--74                                                                   12.3        6.6
   75--79                                                                   10.0        5.4
   80--84                                                                   6.7         3.6
   ≥ 85                                                                     5.1         3.3
  Race/ethnicity                                                                        
   Non-Hispanic white                                                       77.6        63.6
   African American                                                         5.7         6.3
   Hispanic                                                                 10.2        19.6
   Asian, Pacific Islander                                                  5.7         9.7
   Native American/other                                                    0.8         0.8
  Neighborhood SES[a](#tfn4-ehp0113-000993){ref-type="table-fn"}                        
   Low                                                                      13.4        18.4
   Medium-low                                                               25.5        27.4
   Medium-high                                                              29.7        28.5
   High                                                                     31.3        25.7
  Neighborhood urbanization[b](#tfn5-ehp0113-000993){ref-type="table-fn"}               
   Metropolitan urban (most dense)                                          20.8        24.7
   Metropolitan suburb                                                      50.3        45.8
   City                                                                     15.1        14.9
   Small town/rural                                                         13.8        14.6

Based on the distribution of the California census block--group levels of a census-based socioeconomic summary metric incorporating education, income, and occupation (see "Covariate information" for further explanation), and excludes a small number of cases without SES attribute data (n = 49).

Urbanization based on census block--group characteristics (see "Covariate information" for further description).

###### 

Distribution of annual average agricultural pesticide use density (lb/mi^2^) in California census block groups with application ≥ 1 lb/mi^2^ between 1990 and 1997.

  Pesticides/pesticide groups                Block groups[a](#tfn6-ehp0113-000993){ref-type="table-fn"} \[*n* (%)\]   Median   75th percentile   Maximum
  ------------------------------------------ ------------------------------------------------------------------------ -------- ----------------- ---------
  Probable or likely human carcinogens       5,626 (26)                                                               30       221               25,383
  Possible or suggestive human carcinogens   7,004 (33)                                                               19       110               3,628
  Mammary carcinogens                        3,600 (17)                                                               15       52                1,917
  Xenoestrogens                              7,871 (37)                                                               42       354               96,227
  Cholinesterase inhibitors                  6,752 (31)                                                               19       114               6,454
  Organochlorines                            1,633 (8)                                                                6        20                317
  Simazine                                   2,252 (10)                                                               12       39                1,856
  Diuron                                     1,823 (9)                                                                11       28                492
  Oryzalin                                   2,209 (10)                                                               9        25                473
  Propargite                                 2,270 (11)                                                               18       64                1,151
  Methyl bromide                             4,100 (19)                                                               125      669               84,464

Total number of census block groups included in the analysis was 21,515.

###### 

Rate ratios (RR) of invasive breast cancer incidence associated with agricultural pesticide use density in California census block groups.

                                                                    Adjustment for age, race   Adjustment for age, race, urban, SES, race × SES          
  ------------------------------------------ --------- ------------ -------------------------- -------------------------------------------------- ------ --------------
  Probable or likely human carcinogens                                                                                                                   
   \< 1 lb/mi^2^ (low)                       128,931   51,336,520   1.00                                                                          1.00   
   1st--49th percentile                      26,153    10,484,707   0.98                       (0.96--1.00)                                       1.00   (0.98--1.02)
   50th--74th percentile                     11,718    4,878,498    0.93                       (0.90--0.96)                                       0.98   (0.95--1.01)
   ≥ 75th percentile (high)                  9,500     4,268,872    0.89                       (0.86--0.93)                                       1.00   (0.96--1.04)
  Possible or suggestive human carcinogens                                                                                                               
   \< 1 lb/mi^2^ (low)                       117,492   46,546,867   1.00                                                                          1.00   
   1st--49th percentile                      31,964    13,065,368   0.96                       (0.90--1.04)                                       0.98   (0.91--1.06)
   50th--74th percentile                     15,124    6,153,979    0.96                       (0.87--1.06)                                       1.00   (0.90--1.12)
   ≥ 75th percentile (high)                  11,722    5,202,383    0.89                       (0.80--1.00)                                       1.00   (0.87--1.13)
  Mammary carcinogens                                                                                                                                    
   \< 1 lb/mi^2^ (low)                       147,214   58,855,965   1.00                                                                          1.00   
   1st--49th percentile                      15,912    6,530,669    0.96                       (0.94--0.98)                                       1.00   (0.98--1.02)
   50th--74th percentile                     6,951     2,904,907    0.92                       (0.89--0.95)                                       0.99   (0.96--1.03)
   ≥ 75th percentile (high)                  6,225     2,677,057    0.90                       (0.87--0.94)                                       1.01   (0.97--1.04)
  Xenoestrogens                                                                                                                                          
   \< 1 lb/mi^2^ (low)                       109,452   43,326,975   1.00                                                                          1.00   
   1st--49th percentile                      35,670    14,494,059   0.96                       (0.85--1.09)                                       0.99   (0.87--1.12)
   50th--74th percentile                     16,568    6,814,729    0.95                       (0.80--1.12)                                       0.99   (0.83--1.18)
   ≥ 75th percentile (high)                  14,612    6,332,834    0.92                       (0.77--1.10)                                       0.99   (0.82--1.20)
  Anticholinesterase                                                                                                                                     
   \< 1 lb/mi^2^ (low)                       119,297   47,384,054   1.00                                                                          1.00   
   1st--49th percentile                      31,250    12,682,529   0.98                       (0.85--1.13)                                       0.99   (0.85--1.16)
   50th--74th percentile                     14,509    5,879,649    0.96                       (0.78--1.18)                                       1.00   (0.81--1.24)
   ≥ 75th percentile (high)                  11,246    5,022,366    0.89                       (0.71--1.12)                                       0.99   (0.77--1.28)
  Organochlorines                                                                                                                                        
   \< 1 lb/mi^2^ (low)                       164,583   65,912,011   1.00                                                                          1.00   
   1st--49th percentile                      6,698     2,759,649    0.94                       (0.91--0.98)                                       0.99   (0.96--1.03)
   50th--74th percentile                     2,739     1,183,156    0.91                       (0.86--0.96)                                       0.99   (0.94--1.05)
   ≥ 75th percentile (high)                  2,282     1,113,781    0.85                       (0.79--0.90)                                       0.98   (0.92--1.04)
  Simazine                                                                                                                                               
   \< 1 lb/mi^2^ (low)                       158,302   63,559,811   1.00                                                                          1.00   
   1st--49th percentile                      9,452     3,845,789    0.95                       (0.92--0.99)                                       1.00   (0.96--1.04)
   50th--74th percentile                     4,504     1,861,051    0.93                       (0.88--0.98)                                       1.00   (0.95--1.06)
   ≥ 75th percentile (high)                  4,044     1,701,947    0.92                       (0.87--0.97)                                       1.01   (0.95--1.07)
  Diuron                                                                                                                                                 
   \< 1 lb/mi^2^ (low)                       162,056   64,939,678   1.00                                                                          1.00   
   1st--49th percentile                      7,696     3,233,201    0.91                       (0.53--1.58)                                       0.99   (0.55--1.78)
   50th--74th percentile                     3,440     1,461,717    0.91                       (0.40--2.04)                                       1.00   (0.43--2.37)
   ≥ 75th percentile (high)                  3,110     1,334,001    0.91                       (0.39--2.12)                                       1.00   (0.40--2.45)
  Oryzalin                                                                                                                                               
   \< 1 lb/mi^2^ (low)                       159,984   64,007,899   1.00                                                                          1.00   
   1st--49th percentile                      8,948     3,676,123    0.96                       (0.93--0.99)                                       1.00   (0.98--1.03)
   50th--74th percentile                     3,977     1,753,630    0.91                       (0.87--0.95)                                       0.99   (0.95--1.04)
   ≥ 75th percentile (high)                  3,393     1,530,947    0.88                       (0.84--0.92)                                       0.99   (0.95--1.04)
  Propargite                                                                                                                                             
   \< 1 lb/mi^2^ (low)                       159,937   63,771,900   1.00                                                                          1.00   
   1st--49th percentile                      9,241     3,984,021    0.93                       (0.90--0.96)                                       0.98   (0.95--1.01)
   50th--74th percentile                     4,080     1,797,236    0.90                       (0.86--0.94)                                       0.99   (0.95--1.03)
   ≥ 75th percentile (high)                  3,044     1,415,441    0.86                       (0.82--0.91)                                       1.00   (0.95--1.06)
  Methyl bromide                                                                                                                                         
   \< 1 lb/mi^2^ (low)                       142,062   56,718,156   1.00                                                                          1.00   
   1st--49th percentile                      17,334    7,145,385    0.95                       (0.93--0.97)                                       0.98   (0.95--1.00)
   50th--74th percentile                     8,535     3,621,535    0.95                       (0.92--0.98)                                       0.99   (0.96--1.02)
   ≥ 75th percentile (high)                  8,371     3,483,522    0.96                       (0.93--0.99)                                       1.02   (0.99--1.05)

[^1]: The authors declare they have no competing financial interests.
